Growth Metrics

Anaptysbio (ANAB) Cash from Investing Activities (2016 - 2025)

Anaptysbio filings provide 10 years of Cash from Investing Activities readings, the most recent being $73.5 million for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities rose 350.03% year-over-year to $73.5 million, compared with a TTM value of $228.0 million through Dec 2025, up 139.03%, and an annual FY2025 reading of $228.0 million, up 139.03% over the prior year.
  • Cash from Investing Activities hit $73.5 million in Q4 2025 for Anaptysbio, down from $103.3 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $103.3 million in Q3 2025, with the low at -$312.9 million in Q1 2022.
  • Median Cash from Investing Activities over the past 5 years was $26.1 million (2022), compared with a mean of $5.6 million.
  • The sharpest move saw Cash from Investing Activities plummeted 1953.64% in 2021, then soared 1590.7% in 2025.
  • Year by year, Cash from Investing Activities stood at -$66.7 million in 2021, then skyrocketed by 132.23% to $21.5 million in 2022, then surged by 128.77% to $49.2 million in 2023, then tumbled by 159.77% to -$29.4 million in 2024, then skyrocketed by 350.03% to $73.5 million in 2025.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at $73.5 million, $103.3 million, and $36.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.